Melanoma

New data on combination treatments for melanoma

Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according ...

Sep 29, 2014
popularity 0 comments 0

Moles can quadruple risk of developing melanoma

Having moles on your skin can quadruple your risk of developing melanoma, the deadliest type of skin cancer, according to a study released this week by experts at the University of Melbourne, University of ...

Sep 04, 2014
popularity 0 comments 0

Latest Spotlight News

CDC: Hypertension-related deaths on the rise in US

(HealthDay)—The overall death rate from high blood pressure in the United States has increased 23 percent since 2000, even as the death rate from all other causes has dropped 21 percent, health officials ...